DK0060615755
DK0060615755
Ascendis Pharma A/S
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 15.08B EUR | 17.52B EUR | 14.13B EUR | 13.09B EUR |
Enterprise Value | 14.26B EUR | 17.15B EUR | 14.45B EUR | 13.34B EUR |
Valuation Multiples | ||||
Trailing P/E | 17.57x | 23.61x | 28.49x | -- |
Forward P/E | 21.28x | -- | -- | -- |
Price to Sales | 14.41x | 16.73x | 16.32x | 21.14x |
Price to Book | 9.31x | 12.19x | 28.96x | -- |
EV/Revenue | 13.62x | 16.38x | 16.7x | 21.55x |
EV/EBITDA | 54.14x | 54.7x | 1,242.88x | -- |
Price to FCF (P/FCF) | 1,181.06x | 52.27x | 271.73x | 219.15x |
EV/FCF | 1,116.73x | 51.19x | 277.95x | 223.43x |
FCF Yield | 0.08% | 1.91% | 0.37% | 0.46% |